@article {323, title = {Research Policy of the Institutional Review Board in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {15-19}, type = {Review Article}, chapter = {15}, abstract = {

Objectives: This study aims to declare the Research policy of the Institutional Review Board at pharmaceutical care services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the research policy of the Institutional Review Board in pharmacy practice. Results: The Institutional Review Board{\textquoteright}s definition and functions were examined. The policies and procedures have been established. In pharmacy research, there were three distinct categories of actions. That includes Exempted Research, in which no risks to patients are involved. For example, a review of a new program or service, a cost analysis, therapeutic guidelines, review articles, a systematic review, a meta-analysis, or a cross-sectional study. Expedited Research posed little risk to patients. The Complete revision Research has a high risk of adverse effects on patients, such as clinical trials. Conclusion: The Institutional Review Board for research policies in pharmaceutical care services is a new initiative within pharmacy departments{\textquoteright} research and development efforts. The Institutional Review Board for research policies in pharmaceutical care services may enhance pharmacy research and the benefits of investments in pharmacy practice within a healthcare organization. Besides, prevent any adverse events associated with the investigational drug and improve patient clinical outcomes.

}, keywords = {Institutional Review Board, Pharmacy, Policy, Practice, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.4}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {327, title = {Research Policy on Cross-Sectional Studies in Pharmacy Practice}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {31-35}, type = {Review Article}, chapter = {31}, abstract = {

Objectives: This study illustrates the Research policy of Cross-Sectional Studies in Pharmaceutical Care Services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists who specialise in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasises the Pharmacy Research policy of crosssectional studies design. Results: Pharmacy Research{\textquoteright}s policy on cross-sectional studies design in pharmacy practice covered a variety of topics. This includes an examination of the advantages and disadvantages of cross-sectional studies design, as well as the procedures for conducting cross-sectional research in pharmaceutical care services. Conclusion: A novel initiative in pharmacy practice is the development of a pharmacy research strategy that governs the design of cross-sectional studies. The cross-sectional studies used to develop pharmacy policies increased the number and quality of pharmacy research at public and private healthcare organisations. Thus, the cross-sectional design in pharmacy research policy is a basic foundation to implement in Saudi Arabia.

}, keywords = {Cross-sectional, Pharmacy, Policy, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.7}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Ghudair Tashan Alanazi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {332, title = {Research Policy on Research Pharmacist Competency}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {61-64}, type = {Review Article}, chapter = {61}, abstract = {

Objectives: This study explores the Research policy of Research Pharmacist Competency as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacist competency in research practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The English language uses the terms and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of pharmacist competencies in Research. Results: The Pharmacist Competency on Pharmacy Research included several items, such as five modules of clinical pharmacist competencies. That consists of Patient care, research skills, communications, Professionalism, and continuing professional development. In addition, each model included a description of the module of various activities, pre-training and post-training exams, type of assessment, and assessment scores. Conclusion: The pharmacy research policy of Research pharmacist competency is a new initiative and a component of the pharmacy strategic plan. The pharmacy policy{\textquoteright}s research pharmacist competency aims to enhance pharmacists{\textquoteright} research abilities and encourage pharmacists to conduct various types of research in multiple settings within the public and healthcare sectors. Therefore, the Research pharmacist competency policy is critical for the pharmacy career in Saudi Arabia.

}, keywords = {Competency, Pharmacy, Policy, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.12}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {328, title = {Research Quality Management Policy}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {June 2022}, pages = {56-60}, type = {Review Article}, chapter = {56}, abstract = {

Objectives: This study illustrates the Research policy of quality management in pharmacy research practice as a new initiative project in Saudi Arabia. Methods: It is a narrative review of pharmacy research{\textquoteright}s quality management policy and procedures. Litterateur researched specific quality management research policies and procedures in pharmacy practice using various databases, including PubMed, Medline, and Google Scholar. The time covered for the search is from the 1960s to October 2021. The keyword used is in the English language and encompasses systemic reviews, meta-analyses, narrative reviews, and guidelines or regulations. The search term includes all hospital and community pharmacy-related services. Besides, the national and international guidelines for conducting general research in hospital and pharmacy practice. The committee of quality management policy of pharmacy research formulated and consisted of numerous expert members, including clinical pharmacists, drug information pharmacists, and clinical research specialists. A member drafted the policy and procedures, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the quality management of Pharmacy Research policy as the narrative review model. Results: Pharmacy research policy quality management is a new topic in pharmaceutical care services. It covered various topics, the steps involved in conducting quality management, and indicator policies and procedures. Besides, quality management pharmacy research can be implemented into various sections. That included patient care, research skills, communication, Professionalism, cautious development. Each part had a key performance indicator and related optimal level. Conclusion: The quality management policy for pharmacy research is a new initiative within pharmacy research. The quality management pharmacy policy assists the pharmacy research performance and keeps up-to-date development with key performance indicators. Therefore, all quality management models in pharmacy research policy are highly suggested for the pharmacy research practice in Saudi Arabia

}, keywords = {Key performance indicator, Pharmacy, Policy, Quality management, Research, Saudi Arabia.}, doi = {10.5530/ijpcs.2022.11.11}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Maha Hussein Almadany and Abeer Hussin Almasoudi} }